Anthropic just made its first big move into the Asia-Pacific region. On Monday, the company signed a Memorandum of Understanding with the Australian government to collaborate on AI safety research and support the country’s National AI Plan. CEO Dario Amodei flew to Canberra to meet Prime Minister Anthony Albanese and make it official.
This isn’t just a handshake and a photo op. The MOU centers on working with Australia’s AI Safety Institute, sharing findings on emerging model capabilities and risks, running joint safety evaluations, and collaborating with local academic institutions. If this sounds familiar, it should — Anthropic already has similar arrangements with safety institutes in the US, UK, and Japan. The idea is that early access and technical information sharing helps governments build their own independent view of where frontier AI is heading, while developers get feedback to make models safer.
One detail I found interesting: under the MOU, Anthropic will share its Economic Index data with the Australian government. This tracks how AI is being adopted across the economy, its economic impacts, and what it means for workers. The initial focus will be on sectors critical to Australia — natural resources, agriculture, healthcare, and financial services. According to Anthropic’s own data, Australians already use Claude for a broader range of tasks than most countries, and they’re the most diverse users among English-speaking nations. They’re using sophisticated prompts for high-skill work in management, sales, business operations, life sciences, and everyday life. That’s a higher bar than I’d expect from most markets.
The company also announced AUD$3 million in partnerships with four Australian research institutions to use Claude for scientific work. The Australian National University (ANU) is using Claude to analyze genetic sequencing data for rare diseases, and its School of Computing is embedding Claude into new courses. The Garvan Institute of Medical Research is tackling two projects: one with UNSW to translate human genetic variation into insights about disease at the cellular level, and another with the Centre for Population Genomics to automate genetic analysis that’s currently the bottleneck in diagnosing kids with rare conditions. Murdoch Children’s Research Institute is applying Claude to stem cell medicine for childhood heart disease. Curtin University’s Institute for Data Science — Australia’s largest university-based data science institute — will use Claude across health sciences, humanities, business, law, science, and engineering.
Anthropic also launched a deep tech startup API credit program for VC-backed startups working on drug discovery, materials science, climate modeling, and medical diagnostics. Eligible companies get up to USD$50,000 (about AUD$72,000) in API credits, plus resources and community support. This is a smart play — they’re planting seeds in areas where AI can have outsized impact, and building relationships early.
Dario Amodei said: “Australia’s investment in AI safety makes it a natural partner for responsible AI development. This MOU gives our collaboration a formal foundation. I’m particularly excited by the work Australian research institutions will be doing with Claude to advance disease diagnosis and treatment.”
And yes, they’re opening a Sydney office. They’ve already named Theo Hourmouzis as General Manager for Australia and New Zealand. More local team announcements are coming in the next few weeks.
This is a solid move for Anthropic. Australia has been investing in AI safety seriously, and the country’s research institutions are doing genuinely interesting work. The MOU gives them a formal channel to influence safety research while also opening up a market where Claude is already seeing diverse, sophisticated use. The timing makes sense — while everyone’s watching the US and Europe, the Asia-Pacific region is quietly becoming a major AI battleground.
Comments (0)
Login Log in to comment.
Be the first to comment!